Navigation Links
Side-Out Foundation teams with leading medical professionals to battle breast cancer
Date:10/22/2009

Fairfax, VA. (Oct. 22, 2009) -- The Side-Out Foundation and its Dig Pink Volleyball Breast Cancer Awareness campaign will launch a first of its kind clinical trial this month to examine the effects of individualized treatment on patients with metastatic breast cancer. Individualized treatment, known as targeted therapy, provides doctors a better way to tailor cancer treatment and offers the hope of more precisely targeting the cancerous cells, which would reduce side effects and improve quality of life.

The trial protocol will bring together the diverse skills and unique experience of community oncologists, nurses and researchers in the field molecular medicine. Clinical trials will occur at TGen Clinical Research Services (TCRS) at Scottsdale Healthcare and Fairfax Northern Virginia Hematology Oncology. TGen Drug Development Services (TD2) will manage the trial for the Side-Out Foundation. The two major contributing laboratories are CARIS Diagnostics, and George Mason University's Center for Applied Proteomics and Molecular Medicine.

This pilot study follows on the heels of the Bisgrove Trial, which indicated cancer patients can survive longer under treatments based on their individual genetic profiles. Results were reported in April 2009 by TCRS at Scottsdale Healthcare in connection with Caris Dx.

While the Bisgrove Trial was a broader-based solid tumor cancer study, the results of this study indicated the potential clinical benefit of a molecular-based personalized therapy selection strategy for patients with recurrent and/or metastatic disease. Intended to provide real time treatment recommendations to physicians, this metastatic breast cancer trial will be conducted over the next 24 months.

Researchers will utilize these advanced molecular profiling technologies, focusing on tailoring therapy for each patient based on the individual genomic and proteomic molecular portrait within the metastatic lesion itself. The patient would then be treated with a single agent based on the aggregate information provided by the genomic and proteomic molecular profiling analyses.

High schools and colleges across the country will host volleyball matches to "pink-out" the stands this October, Breast Cancer Awareness month, in support of this new research.

The Side-Out Foundation is continuing that momentum by attracting more than 1,000 additional high schools and colleges to compete in similar volleyball tournaments in order to raise $1,000,000 in support of breast cancer research and the social and physiological aspects of the disease .


'/>"/>

Contact: Keith Jones
kjones@shc.org
Scottsdale Healthcare
Source:Eurekalert

Related medicine news :

1. Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation on the Launch of the State of the World's Vaccines and Immunization Report
2. Bill & Melinda Gates Foundation Funds 76 New Ideas to Improve Global Health, From Chewing Gum to Chocolate
3. Bill & Melinda Gates Foundation Rewards 76 New Ideas to Fight Infectious Disease
4. Robert Wood Johnson Foundation, The Pew Charitable Trusts Launch National Initiative to Advance Policies That Promote Health
5. Karmanos Cancer Institute Receives $3 Million Grant from The Herrick Foundation to Launch Challenge Initiative for Cancer Research
6. Hospice Foundation of America Presents Webinar on Grief, Holidays, and Family Dynamics
7. The Regence Foundation Announces Debut of Sojourns Award for Innovation and Leadership in Palliative Care
8. HealthWell Foundation(R) Appoints New Executive Director
9. Philips Healthcare CEO Joins Focused Ultrasound Surgery Foundation Board of Directors
10. Photos: Avon Foundation for Women Celebrates Breast Cancer Awareness Month
11. Univision and Kaiser Foundation Mark National Latino AIDS Awareness Day With New Campaign Featuring People Living With HIV/AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the ... dispensaries and head shops –can’t help but be heartened by the industry’s current surge. ... odor aptly described as “skunk smell.” At last they can simply, safely and ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place in South ... special report in the May issue of Consumer Reports focused on heart health. ... results achieved during and after coronary bypass and aortic valve replacement procedures. , ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG ... Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national ... which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... As part ... Museum today to honor the victims of the Holocaust and Nazi persecution, Center ... at Hadamar and Auschwitz on its CMATH Champions trip to Germany and Poland next ...
(Date:4/24/2017)... ... ... The California Dental Association Foundation’s two-day volunteer dental clinic, CDA Cares ... April 22-23 event at the San Mateo Event Center. , In addition to ... Cares educates the public and policymakers about the importance of good oral health and ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 The Global Effective Microorganisms (EM) ... report has covered and analysed the potential of Global Effective ... size, shares and growth factors. The report identifies and analyses ... in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, spread ...
(Date:4/19/2017)... , April 19, 2017 ... an immune response in pets such as canine, ... are of various types such as Attenuated Live ... Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated live ... virus or bacteria, which have been weakend under ...
(Date:4/19/2017)... , April 19, 2017  Novartis today ... the National Heart, Lung, and Blood Institute (NHLBI) ... that 58% of patients with treatment-naïve severe aplastic ... when treated with eltrombopag at the initiation of ... The study evaluated three sequential treatment groups, or ...
Breaking Medicine Technology: